Literature DB >> 12460887

Frequent microsatellite instability in sporadic tumors of the upper urinary tract.

Arndt Hartmann1, Livia Zanardo, Tina Bocker-Edmonston, Hagen Blaszyk, Wolfgang Dietmaier, Robert Stoehr, John C Cheville, Kerstin Junker, Wolf Wieland, Ruth Knuechel, Josef Rueschoff, Ferdinand Hofstaedter, Richard Fishel.   

Abstract

Urothelial carcinoma of the renal pelvis and ureter may develop sporadically or as a manifestation of hereditary nonpolyposis colorectal cancer. The majority of hereditary nonpolyposis colorectal cancer is caused by mutation of the human DNA mismatch repair (MMR) genes and is detected by associated microsatellite instability (MSI). Seventy-three unselected urothelial carcinomas of the ureter and/or renal pelvis were screened for MSI using the National Cancer Institute-designated reference panel (plus BAT40). Instability of at least two microsatellite markers (MSI-high) was detected in 15 samples (21%). Immunohistochemical staining of the MMR proteins (hMSH2, hMLH1, or hMSH6) was absent in 13 of 15 (87%) MSI tumors, and alteration of coding sequence microsatellites (TGFbetaRII, Bax, hMSH3, and hMSH6) was found at frequencies of 7-33% in these samples. Tumors with MSI had significantly different clinical and histopathological features including higher prevalence in female patients, low tumor stage and grade, and a papillary and frequently inverted growth pattern. Our results suggest a molecular pathway of tumorigenesis that is similar to MMR-deficient colorectal cancers and consistent with the notion that the site distributions of hereditary or sporadic MSI-high tumors may reflect tissue-specific susceptibility to lesions processed by the MMR machinery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12460887

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  28 in total

1.  Spectrum of molecular alterations in colorectal, upper urinary tract, endocervical, and renal carcinomas arising in a patient with hereditary non-polyposis colorectal cancer.

Authors:  Pierre Mongiat-Artus; Catherine Miquel; Jean-François Fléjou; Florence Coulet; Jérôme Verine; Olivier Buhard; Hany Soliman; Pierre Teillac; Françoise Praz
Journal:  Virchows Arch       Date:  2006-04-26       Impact factor: 4.064

2.  Loss of mutL homolog-1 (MLH1) expression promotes acquisition of oncogenic and inhibitor-resistant point mutations in tyrosine kinases.

Authors:  Lorraine Springuel; Elisabeth Losdyck; Pascale Saussoy; Béatrice Turcq; François-Xavier Mahon; Laurent Knoops; Jean-Christophe Renauld
Journal:  Cell Mol Life Sci       Date:  2016-07-19       Impact factor: 9.261

3.  Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987.

Authors:  Joaquim Bellmunt; Hans von der Maase; Graham M Mead; Iwona Skoneczna; Maria De Santis; Gedske Daugaard; Andreas Boehle; Christine Chevreau; Luis Paz-Ares; Leslie R Laufman; Eric Winquist; Derek Raghavan; Sandrine Marreaud; Sandra Collette; Richard Sylvester; Ronald de Wit
Journal:  J Clin Oncol       Date:  2012-02-27       Impact factor: 44.544

4.  Expression of MLH1 and MSH2 in urothelial carcinoma of the renal pelvis.

Authors:  Laleh Ehsani; Adeboye O Osunkoya
Journal:  Tumour Biol       Date:  2014-05-30

5.  Alterations in p53 predict response to preoperative high dose chemotherapy in patients with gastric cancer.

Authors:  F Bataille; P Rümmele; W Dietmaier; D Gaag; F Klebl; A Reichle; P Wild; F Hofstädter; A Hartmann
Journal:  Mol Pathol       Date:  2003-10

6.  [German Association for Bladder Cancer Research].

Authors:  M Retz; A Hartmann; A Merseburger; P Olbert; R Stoehr; R Nawroth
Journal:  Urologe A       Date:  2008-09       Impact factor: 0.639

Review 7.  Genotype to phenotype: analyzing the effects of inherited mutations in colorectal cancer families.

Authors:  Christopher D Heinen
Journal:  Mutat Res       Date:  2009-09-17       Impact factor: 2.433

Review 8.  Surveillance for urinary tract cancer in Lynch syndrome.

Authors:  Inge Thomsen Bernstein; Torben Myrhøj
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

9.  Automated mass action model space generation and analysis methods for two-reactant combinatorially complex equilibriums: an analysis of ATP-induced ribonucleotide reductase R1 hexamerization data.

Authors:  Tomas Radivoyevitch
Journal:  Biol Direct       Date:  2009-12-09       Impact factor: 4.540

10.  Clinical significance of microsatellite instability in sporadic epithelial ovarian tumors.

Authors:  Bo-Sung Yoon; Young-Tae Kim; Jae-Hoon Kim; Sang-Wun Kim; Eun-Ji Nam; Nam-Hoon Cho; Jae-Wook Kim; Sunghoon Kim
Journal:  Yonsei Med J       Date:  2008-04-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.